603 related articles for article (PubMed ID: 33354501)
1. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
Ding C; Song Z; Shen A; Chen T; Zhang A
Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
[TBL] [Abstract][Full Text] [Related]
2. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
3. The role of cGAS-STING signalling in liver diseases.
Chen R; Du J; Zhu H; Ling Q
JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
5. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.
Zhang X; Liu B; Tang L; Su Q; Hwang N; Sehgal M; Cheng J; Ma J; Zhang X; Tan Y; Zhou Y; Duan Z; DeFilippis VR; Viswanathan U; Kulp J; Du Y; Guo JT; Chang J
ACS Infect Dis; 2019 Jul; 5(7):1139-1149. PubMed ID: 31060350
[TBL] [Abstract][Full Text] [Related]
7. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy.
Wang X; Lu X; Yan D; Zhou Y; Tan X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806118
[TBL] [Abstract][Full Text] [Related]
8. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract][Full Text] [Related]
9. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
Zhou S; Cheng F; Zhang Y; Su T; Zhu G
Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA.
Kato K; Omura H; Ishitani R; Nureki O
Annu Rev Biochem; 2017 Jun; 86():541-566. PubMed ID: 28399655
[TBL] [Abstract][Full Text] [Related]
11. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer system.
Brooks T; Wayne J; Massey AJ
Mol Biomed; 2021 Jun; 2(1):19. PubMed ID: 35006469
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria in innate immune signaling.
Banoth B; Cassel SL
Transl Res; 2018 Dec; 202():52-68. PubMed ID: 30165038
[TBL] [Abstract][Full Text] [Related]
14. Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing.
Verrier ER; Langevin C
Front Immunol; 2021; 12():637399. PubMed ID: 33708225
[TBL] [Abstract][Full Text] [Related]
15. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
16. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
Chen R; Liu M; Jiang Q; Meng X; Wei J
Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
[TBL] [Abstract][Full Text] [Related]
17. The Chemistry of the Noncanonical Cyclic Dinucleotide 2'3'-cGAMP and Its Analogs.
Schwede F; Genieser HG; Rentsch A
Handb Exp Pharmacol; 2017; 238():359-384. PubMed ID: 27392950
[TBL] [Abstract][Full Text] [Related]
18. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C
Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189
[TBL] [Abstract][Full Text] [Related]
19. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway.
Bose D; Su Y; Marcus A; Raulet DH; Hammond MC
Cell Chem Biol; 2016 Dec; 23(12):1539-1549. PubMed ID: 27889408
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.
Chen X; Pan X; Zhang W; Guo H; Cheng S; He Q; Yang B; Ding L
Acta Pharm Sin B; 2020 May; 10(5):723-733. PubMed ID: 32528824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
